G1 Therapeutics reports topline data from second phase II trial of trilaciclib in first-line SCLC Nov. 27, 2018
Phase I study demonstrates bioequivalence of CT-P16 with the reference bevacizumab products Nov. 27, 2018
BAT-8001, a potent anti-HER2 antibody-drug conjugate, shows promising preclinical profile Nov. 27, 2018
Gene methylation of nontumoral liver tissue predicts recurrence of HCC after surgical resection Nov. 27, 2018
FDA grants accelerated approval to Vitrakvi for advanced solid tumors with NTRK gene fusion Nov. 27, 2018
RSS